Angiogenesis of breast cancer

被引：269

作者：

Schneider, BP ^{[1
]}

Miller, KD ^{[1
]}

机构：

[1] Indiana Univ, Div Hematol Oncol, Indianapolis, IN 46202 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期

关键词：

D O I：

10.1200/JCO.2005.12.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1782 / 1790

页数：9

共 107 条

[1]

Abrams TJ, 2003, MOL CANCER THER, V2, P1011

[2]

Alpaugh ML, 2001, BREAST CANCER RES TR, V69, P312

[3]

[Anonymous], CANC C HIGHLIGHTS

[4] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].

Asahara, T ;

Masuda, H ;

Takahashi, T ;

Kalka, C ;

Pastore, C ;

Silver, M ;

Kearne, M ;

Magner, M ;

Isner, JM .

CIRCULATION RESEARCH, 1999, 85 (03) :221-228

[5] Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy [J].

Bocci, G ;

Francia, G ;

Man, S ;

Lawler, J ;

Kerbel, RS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) :12917-12922

[6]

Bocci G, 2002, CANCER RES, V62, P6938

[7] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[8]

Bolontrade MF, 2002, CLIN CANCER RES, V8, P3622

[9] Levels of hypoxia-inducible factor-1α during breast carcinogenesis [J].

Bos, R ;

Zhong, H ;

Hanrahan, CF ;

Mommers, ECM ;

Semenza, GL ;

Pinedo, HM ;

Abeloff, MD ;

Simons, JW ;

van Diest, PJ ;

van der Wall, E .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04) :309-314

[10] THE COMBINATION OF ANTIANGIOGENIC AGENTS TO INHIBIT PRIMARY TUMOR-GROWTH AND METASTASIS [J].

BREM, H ;

GRESSER, I ;

GROSFELD, J ;

FOLKMAN, J .

JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (10) :1253-1257

← 1 2 3 4 5 6 7 8 9 10 →